For information about the application process, fee , accommodation and programme, please send your questions to enquiry@siog.org.

Programme

The SIOG Research Masterclass programme offers a comprehensive approach to study design in geriatric oncology. Through expert-led sessions and interactive workshops, participants will explore clinical trial methodologies, observational studies, and cohort designs, all tailored to address the unique challenges of older cancer patients. Each session is crafted to enhance your expertise and empower you to drive meaningful advancements in the field.

Day 1 – Wednesday, April 7th, 2027

Designing Clinical Trials for Older Adults with Cancer

08:30 – 08:50 — Welcome address

08:50 – 09:00 — Introduction to the course

09:00 – 11:00 — Clinical trial presentations by participants
5 min for each participant, no Q&A

11:00 – 11:20 — Networking break

11:20 – 11:40 — Cancer epidemiology in older adults
20 min presentation

11:40 – 12:00 — Why do we still need dedicated clinical research for older adults with cancer?
20 min presentation
Rationale for dedicated trials, evidence gaps, external validity and applicability of trial results to older populations.

12:00 – 12:30 — Designing trials for older adults with cancer: from conventional RCTs to innovative designs
20 min + 10 min discussion
Geriatric-specific eligibility and stratification, adapted treatment strategies, enrichment, alternative endpoints and innovative designs.

12:30 – 13:00 — Choosing outcomes that matter in geriatric oncology trials
20 min + 5 min discussion
Beyond PFS and OS: function, quality of life, independence, treatment burden, tolerability and patient-centered outcomes.

13:00 – 14:00 — Lunch break

14:00 – 17:00 — Workshop I: Building the clinical trial
Participants work in small groups on their protocols with faculty guidance.
Focus: Research question – population – intervention – comparator – design – endpoints.

Day 2 – Thursday, April 8th, 2027

Modern Methodology and Evidence Generation

08:30 – 09:00 — Implementing geriatric assessment in clinical trials
20 min + 10 min discussion
Which domains and tools? Screening versus comprehensive assessment, longitudinal assessment and integration into trial procedures.

09:00 – 09:45 — Pragmatic clinical trials in geriatric oncology
30 min + 15 min discussion
How to design trials that better reflect routine clinical practice: eligibility, recruitment, intervention delivery, comparators and pragmatic endpoints.

09:45 – 10:15 — Networking break

10:15 – 10:45 — Real-world data and observational studies: opportunities and biases
Data sources, confounding, selection bias, immortal-time bias, missing data and interpretation.

10:45 – 11:30 — Target trial emulation and causal inference using real-world data
From the clinical question to the hypothetical target trial: eligibility, treatment strategies, assignment, time zero, outcomes and estimands.

11:30 – 12:15 — Comparative trial design through a geriatric assessment lens (Use case)
15 min each + 15 min discussion
Two faculty members present alternative designs for the same clinical question, with a moderator. Interactive comparison of alternative designs for the same clinical question.

12:15 – 13:30 — Lunch break

13:30 – 14:00 — Digital approaches in oncology and potential in geriatric oncology research
20 min + 10 min discussion
AI-assisted phenotyping and prediction, digital biomarkers, wearables, ePROs, digital therapy, automated data extraction, multimodal data, validation and algorithmic bias — how to design a medical device clinical trial (different methodologies).

14:00 – 15:15 — Debate: Can AI replace geriatric oncology expertise in clinical practice?
Moderated session.

  • FOR the motion
    15 min maximum
  • AGAINST the motion
    15 min maximum
  • Panel discussion and interaction with participants
    35–40 min
  • Audience vote
    Participants vote on the motion following the debate and discussion.

The session will use a debate format, with one speaker arguing in favor of the motion and one speaker arguing against it, followed by an interactive panel discussion and a vote from the participants.

15:15 – 15:45 — Networking break

15:45 – 17:30 — Workshop II: Challenge your trial design
Small-group work with faculty.
Focus: Methodological robustness – representativeness – feasibility – geriatric parameters – potential biases.

Day 3 – Friday, April 9th, 2027

Making Geriatric Oncology Trials Feasible, Meaningful and Translational

08:30 – 09:00 — Measuring treatment tolerability in geriatric oncology research
20 min + 10 min discussion
Toxicity versus tolerability, dose modifications, treatment discontinuation, patient-reported toxicity and composite measures.

09:00 – 09:30 — Integrating patients into clinical research and trial design (with a patient and a caregiver)
20 min + 10 min discussion
Patient engagement from research question to protocol development, endpoints and dissemination.

09:30 – 10:00 — Non-pharmacological and supportive-care interventions: specific methodological challenges
20 min + 10 min discussion

10:00 – 10:30 — Implementation Science
20 min + 10 min discussion

10:30 – 11:00 — Networking break

11:00 – 11:30 — Translational research in geriatric oncology clinical trials
20 min + 10 min discussion
How to integrate biological aging, biomarkers, biospecimens and translational endpoints without overburdening participants.

11:30 – 12:00 — Funding and writing grants for geriatric oncology clinical research
20 min + 10 min discussion

12:00 – 12:30 — Challenges and opportunities in designing industry supported trials
20 min + 10 min discussion

12:30 – 13:00 — From protocol to implementation: conducting geriatric oncology research across different healthcare settings
20 min + 10 min discussion
Academic centers, community settings and resource-limited environments.

13:00 – 14:00 — Lunch break

14:00 – 15:00 — Workshop III: Final protocol clinic
Final work with faculty.
Focus: Feasibility – statistical/methodological coherence – endpoints – recruitment – translational components – final pitch.

15:00 – 16:30 — Final presentations of clinical trials by participants
10 min each: 5 min presentation + 5 min faculty Q&A

16:30 – 17:00 — Key lessons, feedback and closing remarks

DETAILS

Start: April 7, 2027

End: April 9, 2027

Venue: Institut Curie (Paris, France)

Days before Event
0
0
0
0
Days
0
0
Hrs
0
0
Min
0
0
Sec